1. Valencia, A, Masala, E, Rossi, A, Bosi, A, Santini, V. 2013. Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine. In Leukemia, 28, 621-8. doi:10.1038/leu.2013.330. https://pubmed.ncbi.nlm.nih.gov/24192812/
2. Zhang, Heng, Huang, He, Feng, Xing, Shen, Aizong, Qiu, Xingfeng. 2020. Deubiquitinase USP28 inhibits ubiquitin ligase KLHL2-mediated uridine-cytidine kinase 1 degradation and confers sensitivity to 5'-azacytidine-resistant human leukemia cells. In Theranostics, 10, 1046-1059. doi:10.7150/thno.36503. https://pubmed.ncbi.nlm.nih.gov/31938050/
3. van Kuilenburg, André B P, Meinsma, Rutger. 2016. The pivotal role of uridine-cytidine kinases in pyrimidine metabolism and activation of cytotoxic nucleoside analogues in neuroblastoma. In Biochimica et biophysica acta, 1862, 1504-12. doi:10.1016/j.bbadis.2016.05.012. https://pubmed.ncbi.nlm.nih.gov/27239701/
4. Van Rompay, A R, Norda, A, Lindén, K, Johansson, M, Karlsson, A. . Phosphorylation of uridine and cytidine nucleoside analogs by two human uridine-cytidine kinases. In Molecular pharmacology, 59, 1181-6. doi:. https://pubmed.ncbi.nlm.nih.gov/11306702/
智鼠故事 
